You are here

Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Agen, , 47000 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Primary Open Angle (POAG) Glaucoma, Ocular Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female patients,

- Aged > than equal to 18 years,

- Patient presenting with an OHT or OAG with an IOP � 21 mmHg,

- Patient currently treated with ophthalmic beta-blockers monotherapy and requiring a
change of the ophthalmic medication due to insufficient response to treatment,

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patient currently treated by or having received within the last month any ophthalmic
hypotensive agent other than a beta-blocker,

- Patient presenting any contraindication to latanoprost or timolol,

- Patient with history of asthma, obstructive broncho-pneumopathy, sinusal bradycardia
(pulse rate disease or any other condition that would preclude the patient from taking the
prescribed medication,

- Patient with known intolerance to benzalkonium chloride or any excipient contained in
the trial treatment,

NCT00230763
Pfizer
Completed
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now